Eledon Pharmaceuticals, Inc.
ELDN
$3.88
-$0.02-0.51%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.45M | -17.46M | -11.22M | -6.50M | -44.62M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.30M | 1.69M | -9.95M | -7.81M | 27.15M |
| Change in Net Operating Assets | 4.66M | 1.29M | 3.46M | -1.75M | -1.52M |
| Cash from Operations | -14.09M | -14.48M | -17.71M | -16.06M | -18.99M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.46M | 12.41M | 14.96M | 3.89M | -47.38M |
| Cash from Investing | -20.46M | 12.41M | 14.96M | 3.89M | -47.38M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 53.69M | 0.00 | 0.00 | 115.00K | 80.17M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 53.69M | 0.00 | 0.00 | 115.00K | 80.17M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 19.14M | -2.07M | -2.76M | -12.05M | 13.80M |